Wu Xiaobin
SEC CIK 1739452 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ONC | BeOne Medicines Ltd. | Pres, COO, GM China | 0 | — | $92.82M | 42 | 2021-07-06 | 2026-08-25 |
Most active insiders at ONC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | OYLER JOHN | CEO, Dir | — | $327.88M |
| 2 | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | — | $13.37M |
| 3 | Wu Xiaobin | Pres, COO | — | $8.75M |
| 4 | Lee Chan Henry | SVP, GC | — | $7.95M |
| 5 | Wang Lai | Pres, Gbl Head of R, D | — | $1.17M |
| 6 | Sanders Corazon (Corsee) D. | Dir | — | $961.2K |
| 7 | Rosenberg Aaron | CFO | — | $524.4K |
| 8 | BAKER BROS. ADVISORS LP | Dir | — | $262.0K |
| 9 | Ball Titus B. | Principal Accounting Off | — | $127.3K |
| 10 | Dugan Margaret | Dir | — | $65.6K |
Transactions 42
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-27 17:12 | 2026-08-25 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO | S - Sale | $380.00 | -280 | 0 | -100% | -$106.4K |
| 2026-06-25 17:15 | 2026-06-23 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO | S - Sale | $276.26 | -1,292 | 0 | -100% | -$356.9K | |
| 2026-06-18 17:19 | 2026-06-16 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO | S - Sale | $266.76 | -1,357 | 0 | -100% | -$362.0K | |
| D | 2026-06-15 17:55 | 2026-06-11 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO | A - Grant | $0.00 | +118.6K | 1.31M | +10% | $0 |
| D | 2026-06-15 17:55 | 2026-06-11 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO | S - Sale | $261.20 | -626 | 0 | -100% | -$163.5K |
| M | 2026-06-10 17:23 | 2026-06-08 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO | S - Sale | $269.37 | -1,484 | 0 | -100% | -$399.7K |
| M | 2026-03-10 | 2026-03-06 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO | A - Grant | $0.00 | +247.5K | 1.22M | +26% | $0 |
| M | 2025-11-19 | 2025-11-17 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO | S - Sale | $380.43 | -3,991 | 836 | -83% | -$1.52M |
| M | 2025-11-14 | 2025-11-12+ | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO | S - Sale | $365.22 | -16.0K | 1,769 | -90% | -$5.85M |
| DM | 2025-08-15 | 2025-08-13+ | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO | S - Sale+OE | $304.56 | -89.8K | 33.7K | -73% | -$27.35M |
| DM | 2025-08-15 | 2025-08-13+ | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO | M - OptEx | $160.78 | +89.8K | 22.8K | New | +$14.44M |
| 2025-06-25 | 2025-06-23 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO | S - Sale | $260.00 | -1,363 | 0 | -100% | -$354.4K | |
| M | 2025-06-18 | 2025-06-16+ | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO | S - Sale | $261.27 | -2,173 | 730 | -75% | -$567.7K |
| D | 2025-06-12 | 2025-06-10 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO | A - Grant | $0.00 | +123.4K | 1.27M | +11% | $0 |
| M | 2025-06-10 | 2025-06-06 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO | S - Sale | $253.15 | -1,934 | 1,534 | -56% | -$489.6K |
| DM | 2025-04-03 | 2025-04-01 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | S - Sale+OE | $281.39 | -51.9K | 5,083 | -91% | -$14.61M |
| DM | 2025-04-03 | 2025-04-01 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | M - OptEx | $157.14 | +51.9K | 16.5K | New | +$8.16M |
| I | 2025-03-18 | 2025-03-14 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | S - Sale | — | 0 | 0 | New | — |
| D | 2025-03-07 | 2025-03-05 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | A - Grant | $0.00 | +103.9K | 1.18M | +10% | $0 |
| DM | 2025-03-07 | 2025-03-05 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | M - OptEx | $126.71 | +51.9K | 51.9K | New | +$6.58M |
| DM | 2025-03-07 | 2025-03-05 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | S - Sale+OE | $261.59 | -51.9K | 0 | -100% | -$13.58M |
| I | 2025-03-04 | 2025-02-28 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | S - Sale | — | 0 | 0 | New | — |
| DM | 2025-02-20 | 2025-02-18+ | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | S - Sale+OE | $240.46 | -51.9K | 11.1K | -82% | -$12.49M |
| DM | 2025-02-20 | 2025-02-18+ | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | M - OptEx | $169.65 | +51.9K | 30.7K | New | +$8.81M |
| I | 2024-12-10 | 2024-12-06 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | S - Sale | — | 0 | 0 | New | — |
| M | 2024-09-19 | 2024-09-17+ | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | S - Sale | $200.13 | -5,000 | 4,500 | -53% | -$1.00M |
| M | 2024-09-05 | 2024-09-03 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | S - Sale | $189.65 | -5,556 | 274 | -95% | -$1.05M |
| M | 2024-06-26 | 2024-06-24 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | S - Sale | $159.79 | -1,459 | 0 | -100% | -$233.1K |
| M | 2024-06-20 | 2024-06-17+ | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | S - Sale | $155.26 | -3,254 | 300 | -92% | -$505.2K |
| D | 2024-06-07 | 2024-06-05 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | A - Grant | $0.00 | +253.4K | 1.27M | +25% | $0 |
| 2023-06-27 | 2023-06-26 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | S - Sale | $182.37 | -1,495 | 0 | -100% | -$272.6K | |
| D | 2023-06-20 | 2023-06-15 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | A - Grant | $0.00 | +200.4K | 1.03M | +24% | $0 |
| D | 2023-06-20 | 2023-06-20 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | S - Sale | $192.44 | -1,753 | 0 | -100% | -$337.3K |
| M | 2023-06-09 | 2023-06-07 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | S - Sale | $224.73 | -3,291 | 2,760 | -54% | -$739.6K |
| 2023-05-10 | 2023-05-08 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | S - Sale | $253.72 | -7,000 | 0 | -100% | -$1.78M | |
| D | 2022-06-24 | 2022-06-22 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | A - Grant | $0.00 | +187.9K | 987.9K | +23% | $0 |
| M | 2022-06-22 | 2022-06-17+ | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | S - Sale | $142.63 | -1,588 | 1,010 | -61% | -$226.5K |
| 2022-06-08 | 2022-06-06 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | S - Sale | $141.99 | -3,410 | 0 | -100% | -$484.2K | |
| M | 2022-05-06 | 2022-05-05 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | S - Sale | $164.35 | -6,725 | 1,300 | -84% | -$1.11M |
| I | 2021-12-17 | 2021-12-15 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | A - Grant | — | 0 | 0 | New | — |
| M | 2021-11-10 | 2021-11-08+ | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | S - Sale | $358.27 | -10.0K | 5,433 | -65% | -$3.58M |
| M | 2021-07-08 | 2021-07-06 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Pres, COO, GM China | S - Sale | $325.53 | -10.2K | 0 | -100% | -$3.31M |
Purchase Sale Sale after option exercise All abbreviations